Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
BRIEF: Teva files for Copaxone-Laquinimod patent
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Dimethylfumarate induces apoptosis in human mast cells.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Reassessing the risk of natalizumab-associated PML.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.

Pages